The impact of screening for propionic and methylmalonic acidaemia

European Journal of Pediatrics, Supplement

Volumn 162, Issue 1, 2003, Pages

  Leonard, James V ^a   Vijayaraghavan, Suresh ^b   Walter, John H ^b  

^a UNIVERSITY COLLEGE LONDON   (United Kingdom)

^b ROYAL MANCHESTER CHILDREN S HOSPITAL   (United Kingdom)

Author keywords

Neonatal screening; Organic acidaemia; Tandem mass spectrometry

Indexed keywords

ANTIINFECTIVE AGENT; CYANOCOBALAMIN; METHYLMALONIC ACID; METRONIDAZOLE; PROPIONIC ACID;

BIOAVAILABILITY; CONCENTRATION RESPONSE; CONFERENCE PAPER; DIAGNOSTIC TEST; DISEASE SEVERITY; HUMAN; LONG TERM CARE; METHYLMALONIC ACIDEMIA; PRIORITY JOURNAL; PROPIONIC ACIDEMIA; PROTEIN RESTRICTION; SCREENING TEST; TANDEM MASS SPECTROMETRY;

EID: 0347950966     PISSN: 09439676     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00431-003-1345-1     Document Type: Conference Paper

References (17)

1. Ades AE, Walker J, Jones R, Thompson S, Leonard JV, Smith I (1998) Obstacles to timely neonatal screening in North Thames. J Med Screen 5: 183-186
2. Baumgartner ER, Viardot C (1995) Long-term follow up of 77 patients with isolated methylmalonic acidaemia. J Inherit Metab Dis 18: 138-142
3. De Sousa C, Piesowicz AT, Brett EM, Leonard JV (1989) Focal changes in the globi pallidi associated with neurological dysfunction in methylmalonic acidaemia. Neuropediatrics 20: 199-201
4. Ledley FD, Levy HL, Shih VE, Benjamin R, Mahoney MJ (1984) Benign methylmalonic aciduria. N Engl J Med 311: 1015-1018
5. Lehnert W, Sperl W, Suormala T, Baumgartner ER (1994) Propionic acidaemia: clinical, biochemical and therapeutic aspects. Eur J Paediatr 153[Suppl 1]: S68-S80
6. Leonard JV (1995) The management and outcome of propionic and methylmalonic acidaemia. J Inherit Metab Dis 18: 430-434
7. Leonard JV, Walter JH, McKiernan PJ (2001) The management of organic acidaermias: the role of transplantation. J Inherit Metab Dis 24: 309-311
8. Matsui SM, Mahoney MJ, Rosenberg LE (1983) The natural history of the inherited methylmalonic acidemias. N Engl J Med 308: 857-861
9. Nicolaides P, Leonard JV, Surtees RAH (1998) Neurological outcome of methylmalonic acidaemia. Arch Dis Child 78: 508-512
10. Rousson R, Guibaud P (1984) Long-term outcome of organic acidurias: survey of 105 French cases (1967-1983) J Inherit Metab Dis 7[Suppl 1]: 10-12
11. Shevell MI, Matiaszuk N, Ledley FD, Rosenblatt DS (1993) Varying neurological phenotypes among mut0 amd mut- patients with methylmalonyl CoA mutase deficiency. Am J Med Genet 45: 619-624
12. Sniderman LC, Lambert M, Giguere R, Auray-Blais C, Lemieux B (1999) Outcome of individuals with low-moderate methylmalonic aciduria detected through neonatal screening program. J Pediatr 134: 675-680
13. Surtees RAH, Matthews EE, Leonard JV (1992) Neurologic outcome of propionic acidaemia. Pediatr Neurol 8: 333-337
14. 12 unresponsive methylmalonic acidaemia. J Pediatr 125: 903-908
15. Van der Meer SB, Poggi F, Spada M, Bonnefont JP, Ogier H, Hubert P, Depondt E, Rapoport D, Rabier D, Charpentier C, Parvy P, Bardet J, Kamoun P, Saudubray J-M (1996) Clinical outcome and long-term management of 17 patients with propionic acidaemia. Eur J Pediatr 155: 205-210
16. Van't Hoff W, McKiernan PJ, Surtees RAH, Leonard JV (1999) Liver transplantation for methylmalonic acidaemia. Eur J Pediatr 158[Suppl 1]: S70-S74
17. Zytkovicz TH, Fitzgerald EF, Marsden D, Larson CA, Shih VE, Johnson DM, Strauss AW, Comeau AM, Eaton RB, Grady GF (2001) Tandem mass spectrometric analysis for amino, organic, and fatty acid disorders in newborn dried blood spots. A two-year summary from the New England Newborn Screening Program. Clin Chem 47: 1945-1955